ISS urges Illumina holders to reject Roche proposals

NEW YORK (Reuters) – A major shareholders advisory service on Friday urged holders of U.S. gene sequencing company Illumina to vote against rejected suitor Roche Holdings AG’s proxy contest to expand Illumina’s board and fill it with its own nominees.


Reuters: Health News